Association of genetic variation in mitotic kinases with breast cancer risk

Breast Cancer Research and Treatment

Volumn 119, Issue 2, 2010, Pages 453-462

  Wang, Xianshu ^a   Fredericksen, Zachary S ^a   Vierkant, Robert A ^a   Kosel, Matthew L ^a   Pankratz, V Shane ^a   Cerhan, James R ^a   Justenhoven, Christina ^b   Brauch, Hiltrud ^b   Olson, Janet E ^a   Couch, Fergus J ^a  

^a Mayo Clinic   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Breast cancer risk; Haplotype; Mitosis; Mitotic kinase; Single nucleotide polymorphism (SNP)

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MITOTIC KINASE; PROGESTERONE RECEPTOR; PROTEIN KINASE; PROTEIN KINASE FYN; PROTEIN MAP2K4; PROTEIN MAST2; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ANEUPLOIDY; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CAUCASIAN; CHROMOSOMAL INSTABILITY; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LOGISTIC MODELS; MIDWESTERN UNITED STATES; MITOSIS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN KINASES; RISK ASSESSMENT; RISK FACTORS;

EID: 74849114007     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0404-3     Document Type: Article

References (43)

1. H Zhou J Kuang L Zhong WL Kuo JW Gray A Sahin BR Brinkley S Sen 1998 Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation Nat Genet 20 189 193 10.1038/2496 10.1038/2496 1:CAS:528:DyaK1cXms1eis78%3D 9771714 (Pubitemid 28455454)
2. KE Mundt RM Golsteyn HA Lane EA Nigg 1997 On the regulation and function of human polo-like kinase 1 (PLK1): effects of overexpression on cell cycle progression Biochem Biophys Res Commun 239 377 385 10.1006/bbrc.1997.7378 10.1006/bbrc.1997.7378 1:CAS:528:DyaK2sXntVOrtbk%3D 9344838 (Pubitemid 27488972)
3. WL Lingle SL Barrett VC Negron AB D'Assoro K Boeneman W Liu CM Whitehead C Reynolds JL Salisbury 2002 Centrosome amplification drives chromosomal instability in breast tumor development Proc Natl Acad Sci USA 99 1978 1983 10.1073/pnas.032479999 10.1073/pnas.032479999 1:CAS:528:DC%2BD38XitVSrsL0%3D 11830638 (Pubitemid 34169000)
4. JJ Li SA Li 2006 Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis Pharmacol Ther 111 974 984 10.1016/j.pharmthera.2006.02.006 10.1016/j.pharmthera.2006.02.006 1:CAS:528:DC%2BD28Xns1SksLk%3D 16603252 (Pubitemid 44137383)
5. T Tanaka M Kimura K Matsunaga D Fukada H Mori Y Okano 1999 Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast Cancer Res 59 2041 2044 1:CAS:528:DyaK1MXjtVWjsrc%3D 10232583
6. J Yuan A Horlin B Hock HJ Stutte H Rubsamen-Waigmann K Strebhardt 1997 Polo-like kinase, a novel marker for cellular proliferation Am J Pathol 150 1165 1172 1:CAS:528:DyaK2sXis12iu7Y%3D 9094972
7. DG Hayward RB Clarke AJ Faragher MR Pillai IM Hagan AM Fry 2004 The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer Cancer Res 64 7370 7376 10.1158/0008-5472.CAN-04-0960 10.1158/0008-5472.CAN-04-0960 1:CAS:528:DC%2BD2cXosFyntLc%3D 15492258 (Pubitemid 39372076)
8. EA Harrington D Bebbington J Moore RK Rasmussen AO Ajose-Adeogun T Nakayama JA Graham C Demur T Hercend A Diu-Hercend, et al. 2004 VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo Nat Med 10 262 267 10.1038/nm1003 10.1038/nm1003 1:CAS:528:DC%2BD2cXhs1Wnur4%3D 14981513 (Pubitemid 38667616)
9. B Spankuch S Heim E Kurunci-Csacsko C Lindenau J Yuan M Kaufmann K Strebhardt 2006 Down-regulation of Polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivo Cancer Res 66 5836 5846 10.1158/0008-5472.CAN-06-0343 10.1158/0008-5472.CAN-06-0343 16740723 (Pubitemid 43927138)
10. P Finetti N Cervera E Charafe-Jauffret C Chabannon C Charpin M Chaffanet J Jacquemier P Viens D Birnbaum F Bertucci 2008 Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis Cancer Res 68 767 776 10.1158/0008-5472.CAN-07-5516 10.1158/0008-5472.CAN-07-5516 1:CAS:528: DC%2BD1cXhtlygsbw%3D 18245477 (Pubitemid 351206753)
11. A Ewart-Toland Q Dai YT Gao H Nagase MG Dunlop SM Farrington RA Barnetson H Anton-Culver D Peel A Ziogas, et al. 2005 Aurora-A/STK15 T + 91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types Carcinogenesis 26 1368 1373 10.1093/carcin/bgi085 10.1093/carcin/bgi085 1:CAS:528:DC%2BD2MXmsV2isLc%3D 15802297 (Pubitemid 41417879)
12. YL Lo JC Yu ST Chen GC Hsu YC Mau SL Yang PE Wu CY Shen 2007 Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility Carcinogenesis 28 1079 1086 10.1093/carcin/bgl256 10.1093/carcin/bgl256 1:CAS:528:DC%2BD2sXlvFGlsbg%3D 17210994 (Pubitemid 47072194)
13. DF Easton KA Pooley AM Dunning PD Pharoah D Thompson DG Ballinger JP Struewing J Morrison H Field R Luben, et al. 2007 Genome-wide association study identifies novel breast cancer susceptibility loci Nature 447 1087 1093 10.1038/nature05887 10.1038/nature05887 1:CAS:528:DC%2BD2sXmvFKmurc%3D 17529967 (Pubitemid 47014426)
14. M Bettencourt-Dias R Giet R Sinka A Mazumdar WG Lock F Balloux PJ Zafiropoulos S Yamaguchi S Winter RW Carthew, et al. 2004 Genome-wide survey of protein kinases required for cell cycle progression Nature 432 980 987 10.1038/nature03160 10.1038/nature03160 1:CAS:528:DC%2BD2cXhtFeisrbL 15616552 (Pubitemid 40052222)
15. X Wang EL Goode ZS Fredericksen RA Vierkant VS Pankratz W Liu-Mares DN Rider CM Vachon JR Cerhan JE Olson FJ Couch 2008 Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer Cancer Epidemiol Biomarkers Prev 17 2101 2108 10.1158/1055-9965.EPI-08-0134 10.1158/1055-9965.EPI-08-0134 1:CAS:528: DC%2BD1cXpvFKmsb8%3D 18708403
16. LE Kelemen FJ Couch S Ahmed AM Dunning PD Pharoah DF Easton ZS Fredericksen RA Vierkant VS Pankratz EL Goode CG Scott DN Rider X Wang JR Cerhan CM Vachon 2008 Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies Breast Cancer Res 10 R98 10.1186/bcr2201 10.1186/bcr2201 19036156
17. B Pesch Y Ko H Brauch U Hamann V Harth S Rabstein C Pierl HP Fischer C Baisch C Justenhoven, et al. 2005 Factors modifying the association between hormone-replacement therapy and breast cancer risk Eur J Epidemiol 20 699 711 10.1007/s10654-005-0032-0 10.1007/s10654-005-0032-0 16151884 (Pubitemid 41266867)
18. C Justenhoven CB Pierl S Haas HP Fischer C Baisch U Hamann V Harth B Pesch T Bruning C Vollmert, et al. 2008 The CYP1B1-1358-GG genotype is associated with estrogen receptor-negative breast cancer Breast Cancer Res Treat 111 171 177 10.1007/s10549-007-9762-x 10.1007/s10549-007-9762-x 1:CAS:528:DC%2BD1cXos1Wntrc%3D 17922187 (Pubitemid 352009231)
19. International HapMap Consortium, et al. 2005 A haplotype map of the human genome Nature 437 1299 1320 10.1038/nature04226 10.1038/nature04226 (Pubitemid 41568671)
20. Z Meng DV Zaykin CF Xu M Wagner MG Ehm 2003 Selection of genetic markers for association analyses, using linkage disequilibrium and haplotypes Am J Hum Genet 73 115 130 10.1086/376561 10.1086/376561 1:CAS:528:DC%2BD3sXlsVOitLY%3D 12796855 (Pubitemid 36793785)
21. NE Breslow NE Day 1987 Statistical methods in cancer research IARC Workshop IARC Sci Publ 1987 1 406
22. JD Storey R Tibshirani 2003 Statistical significance for genomewide studies Proc Natl Acad Sci USA 100 9440 9445 10.1073/pnas.1530509100 10.1073/pnas.1530509100 1:CAS:528:DC%2BD3sXmtlyktbY%3D 12883005 (Pubitemid 37033947)
23. SB Gabriel SF Schaffner H Nguyen JM Moore J Roy B Blumenstiel J Higgins M DeFelice A Lochner M Faggart, et al. 2002 The structure of haplotype blocks in the human genome Science 296 2225 2229 10.1126/science.1069424 10.1126/science.1069424 1:CAS:528:DC%2BD38XkvFGhtrc%3D 12029063 (Pubitemid 34680308)
24. SL Lake H Lyon K Tantisira EK Silverman ST Weiss NM Laird DJ Schaid 2003 Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous Hum Hered 55 56 65 10.1159/000071811 10.1159/000071811 1:STN:280:DC%2BD3szlvVWjug%3D%3D 12890927 (Pubitemid 36928747)
25. J Marchini P Donnelly LR Cardon 2005 Genome-wide strategies for detecting multiple loci that influence complex diseases Nat Genet 37 413 417 10.1038/ng1537 10.1038/ng1537 1:CAS:528:DC%2BD2MXislCmu7g%3D 15793588
26. MP Cooke KM Abraham KA Forbush RM Perlmutter 1991 Regulation of T cell receptor signaling by a src family protein-tyrosine kinase (p59fyn) Cell 65 281 291 10.1016/0092-8674(91)90162-R 10.1016/0092-8674(91)90162-R 1:CAS:528:DyaK3MXit1Oiur0%3D 2015626
27. E Calautti M Grossi C Mammucari Y Aoyama M Pirro Y Ono J Li GP Dotto 2002 Fyn tyrosine kinase is a downstream mediator of Rho/PRK2 function in keratinocyte cell-cell adhesion J Cell Biol 156 137 148 10.1083/jcb.200105140 10.1083/jcb.200105140 1:CAS:528:DC%2BD38XjslOgsQ%3D%3D 11777936 (Pubitemid 34846942)
28. KD Sorensen M Borre TF Orntoft L Dyrskjot N Torring 2008 Chromosomal deletion, promoter hypermethylation and downregulation of FYN in prostate cancer Int J Cancer 122 509 519 10.1002/ijc.23136 10.1002/ijc.23136 17943724 (Pubitemid 350308941)
29. B Berwanger O Hartmann E Bergmann S Bernard D Nielsen M Krause A Kartal D Flynn R Wiedemeyer M Schwab, et al. 2002 Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma Cancer Cell 2 377 386 10.1016/S1535-6108(02)00179-4 10.1016/S1535-6108(02)00179-4 1:CAS:528:DC%2BD38Xptlalur0%3D 12450793 (Pubitemid 41039104)
30. H Ishiguro T Saito H Shibuya M Toru T Arinami 2000 Mutation and association analysis of the Fyn kinase gene with alcoholism and schizophrenia Am J Med Genet 96 716 720 10.1002/1096-8628(20001204)96:6<716::AID-AJMG3>3. 0.CO;2-N 10.1002/1096-8628(20001204)96:6<716::AID-AJMG3>3.0.CO;2-N 1:STN:280:DC%2BD3M%2FmsVKltA%3D%3D 11121167
31. T Watanabe T Ohnuma N Shibata M Ohtsuka A Ueki M Nagao H Arai 2004 No genetic association between Fyn kinase gene polymorphisms (-93A/G, IVS10 + 37T/C and Ex12 + 894T/G) and Japanese sporadic Alzheimer's disease Neurosci Lett 360 109 111 10.1016/j.neulet.2004.02.046 10.1016/j.neulet.2004.02.046 1:CAS:528:DC%2BD2cXjtV2ntLs%3D 15082191 (Pubitemid 38472000)
32. LH Saal K Holm M Maurer L Memeo T Su X Wang JS Yu PO Malmstrom M Mansukhani J Enoksson, et al. 2005 PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma Cancer Res 65 2554 2559 10.1158/0008-5472-CAN-04-3913 10.1158/0008-5472-CAN-04-3913 1:CAS:528:DC%2BD2MXjtVeqsrc%3D 15805248 (Pubitemid 40490050)
33. B Joshi SS Strugnell JG Goetz LD Kojic ME Cox OL Griffith SK Chan SJ Jones SP Leung H Masoudi, et al. 2008 Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion Cancer Res 68 8210 8220 10.1158/0008-5472.CAN-08-0343 10.1158/0008-5472.CAN-08- 0343 1:CAS:528:DC%2BD1cXht1Cmsb%2FE 18922892
34. Z Li X Dong Z Wang W Liu N Deng Y Ding L Tang T Hla R Zeng L Li, et al. 2005 Regulation of PTEN by Rho small GTPases Nat Cell Biol 7 399 404 10.1038/ncb1236 10.1038/ncb1236 1:CAS:528:DC%2BD2MXivVakt7s%3D 15793569 (Pubitemid 40533130)
35. J Lane TA Martin G Watkins RE Mansel WG Jiang 2008 The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer Int J Oncol 33 585 593 1:CAS:528:DC%2BD1cXht1Wmu7vJ 18695890
36. DH Teng WL Perry 3rd JK Hogan M Baumgard R Bell S Berry T Davis D Frank C Frye T Hattier, et al. 1997 Human mitogen-activated protein kinase 4 as a candidate tumor suppressor Cancer Res 57 4177 4182 1:CAS:528:DyaK2sXmsFChtbo%3D 9331070
37. GH Su W Hilgers MC Shekher DJ Tang CJ Yeo RH Hruban SE Kern 1998 Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene Cancer Res 58 2339 2342 1:CAS:528:DyaK1cXjs12ru7k%3D 9622070
38. GH Su JJ Song EA Repasky M Schutte SE Kern 2002 Mutation rate of MAP2K4/MKK4 in breast carcinoma Hum Mutat 19 81 10.1002/humu.9002 10.1002/humu.9002 11754110
39. A Couvelard J Hu G Steers D O'Toole A Sauvanet J Belghiti P Bedossa K Gatter P Ruszniewski F Pezzella 2006 Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors Gastroenterology 131 1597 1610 10.1053/j.gastro.2006.09.007 10.1053/j.gastro. 2006.09.007 1:CAS:528:DC%2BD28Xhtlant77I 17064702 (Pubitemid 44780863)
40. SD Yamada JA Hickson Y Hrobowski DJ Vander Griend D Benson A Montag T Karrison D Huo J Rutgers S Adams, et al. 2002 Mitogen-activated protein kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma Cancer Res 62 6717 6723 1:CAS:528:DC%2BD38XovFOksb4%3D 12438272
41. NB Adey L Huang PA Ormonde ML Baumgard R Pero DV Byreddy SV Tavtigian PL Bartel 2000 Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding Cancer Res 60 35 37 1:CAS:528: DC%2BD3cXnt1ahsA%3D%3D 10646847
42. M Valiente A Andres-Pons B Gomar J Torres A Gil C Tapparel SE Antonarakis R Pulido 2005 Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases J Biol Chem 280 28936 28943 10.1074/jbc.M504761200 10.1074/jbc. M504761200 1:CAS:528:DC%2BD2MXntVehu7k%3D 15951562 (Pubitemid 41161339)
43. N Dey HE Crosswell P De R Parsons Q Peng JD Su DL Durden 2008 The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration Cancer Res 68 1862 1871 10.1158/0008-5472.CAN-07-1182 10.1158/0008-5472.CAN-07-1182 1:CAS:528:DC%2BD1cXjtFOhsbo%3D 18339867